Clin2
NCT06213857Possibly a fitRecruiting

Silymarin for ulcerative colitis

Ulcerative Colitis

Treatments studied

Part of Digestive system clinical trials.

This study tests whether silymarin (an extract from milk thistle) can help treat ulcerative colitis when added to your usual treatment. It may reduce inflammation and oxidative stress in the colon.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
44 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be between 18 and 65 years old.
  • You cannot have serious kidney or liver problems.
  • You cannot be pregnant, breastfeeding, or a smoker.
  • You cannot be taking corticosteroids (e.g., prednisone) or biologic medicines for your colitis.
  • You cannot be taking any other antioxidant supplements like vitamin E or CoQ10.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06525974Not yet recruiting· Early Phase 1
Febuxostat added to mesalamine for ulcerative colitis

This trial tests whether adding febuxostat, a medicine usually used for gout, can help reduce inflammation in people with mild to moderate ulcerative colitis who are already taking mesalamine. It aims to see if this combination is safe and effective.

NCT07265570Recruiting· Phase 2
ISM5411 for active ulcerative colitis

This trial tests an experimental drug (ISM5411) for people with active ulcerative colitis. The goal is to see if the drug can reduce inflammation and improve symptoms.

Beijing, Beijing Municipality
NCT06420375Recruiting· Phase 2
New treatment for active ulcerative colitis

This trial tests a new treatment for people with ulcerative colitis (UC) whose disease is active despite taking only mesalamine or sulfasalazine. It aims to find a therapy that can reduce inflammation and improve symptoms.

Chestnut Hill, Massachusetts
NCT06335160Recruiting
Mebendazole for mild to moderate ulcerative colitis

This study tests adding a medicine called mebendazole (normally used for parasites) to standard mesalamine treatment for people with mild or moderate ulcerative colitis. The goal is to see if it helps control inflammation better than mesalamine alone.

Tanta
NCT06784323Recruiting
Anti-inflammatory diet for Americans with ulcerative colitis

This trial tests whether a tailored anti-inflammatory diet based on American foods can help people with mild to moderately active ulcerative colitis. You'll follow a special meal plan with foods like soup, smoothies, salmon, and avocado, and researchers will track your symptoms and inflammation.

Miami, Florida
NCT07123922Enrolling by invitation
Silymarin for COPD: A Study on Breathing and Quality of Life

This study tests whether adding silymarin (a herbal supplement from milk thistle) to your regular COPD treatment can improve your lung function, reduce stress in your body, and help you feel better day-to-day.

Dhaka

Hear when a new Ulcerative Colitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.